ALPINE 4 HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.75 USD | 0.00% |
|
-0.13% | +2.04% |
| 2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
| 2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 0.8150 | 1.190 | 1.200 |
| Spread/Res. | -7.98% | -36.97% | -37.50% |
| Spread/Supp. | +8.38% | +39.93% | +37.61% |
| Support | 0.6920 | 0.5360 | 0.5450 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ALPP Stock
- Charts Alpine 4 Holdings, Inc.
